As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.

A study showed that base editing can repair mutations linked to a rare liver disease. The therapy restored liver and cellular ...

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...

"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature Communications publication. In the study, Chappell describes ...

Researchers have built a synthetic-cell platform that can be chemically adjusted in real time, sidestepping a long-standing ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for creating insulin-producing cells from human stem cells. The results, ...

A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...

CiQUS researchers introduces an innovative chemical strategy to create biomimetic structures with greater efficiency. The design of more versatile and controllable synthetic cells could unlock new ...

They may look harmless, but they're certainly capable of turning your spreadsheets into traffic jams.

Synthetic biologists were tantalized by the idea of making mirror images of microbes. Then things got complicated.

A team at the Center for Research in Biological Chemistry and Molecular Materials (CiQUS) at the University of Santiago de Compostela has developed a more flexible chemical strategy to create ...